tradingkey.logo


tradingkey.logo


Koninklijke Philips NV

PHG
27.350USD
+0.620+2.32%
āđ€āļ§āļĨāļēāļ—āļģāļāļēāļĢāļ•āļĨāļēāļ” ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
26.02BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
25.70P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Koninklijke Philips NV āļšāļĢāļīāļĐāļąāļ—

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

āļ‚āđ‰āļ­āļĄāļđāļĨ Koninklijke Philips NV


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™PHG
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Koninklijke Philips NV
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļSep 18, 2009
āļ‹āļĩāļ­āļĩāđ‚āļ­Jakobs (Roy)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™67823
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒDepository Receipt
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Sep 18
āļ—āļĩāđˆāļ­āļĒāļđāđˆHigh Tech Campus 5
āđ€āļĄāļ·āļ­āļ‡EINDHOVEN
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻNetherlands
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ5656 AE
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ31205977777
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.philips.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™PHG
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļSep 18, 2009
āļ‹āļĩāļ­āļĩāđ‚āļ­Jakobs (Roy)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Koninklijke Philips NV


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Mr. Leandro Mazzoni
Mr. Leandro Mazzoni
Head of Investor Relations
Head of Investor Relations
--
--
Ms. Deeptha Khanna
Ms. Deeptha Khanna
Executive Vice President, Chief Business Leader Personal Health
Executive Vice President, Chief Business Leader Personal Health
--
--
Mr. Peter Loescher
Mr. Peter Loescher
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Feike Sijbesma
Mr. Feike Sijbesma
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
North America
2.14B
42.61%
Growth geographies
1.42B
28.29%
Western Europe
1.09B
21.69%
Other Mature geographies
374.02M
7.44%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 4 āļĄāļĩ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 4 āļĄāļĩ.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.69%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.23%
āļ­āļ·āđˆāļ™ āđ†
97.51%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.69%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.23%
āļ­āļ·āđˆāļ™ āđ†
97.51%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
4.05%
Investment Advisor/Hedge Fund
0.77%
Research Firm
0.25%
Hedge Fund
0.15%
Family Office
0.07%
Family Office
0.04%
Family Office
0.04%
Bank and Trust
0.02%
Venture Capital
0.01%
āļ­āļ·āđˆāļ™ āđ†
94.59%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
586
50.66M
5.33%
-12.53M
2025Q3
564
51.04M
5.37%
-17.40M
2025Q2
560
58.95M
6.20%
-8.73M
2025Q1
579
60.52M
6.54%
-8.45M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Mondrian Investment Partners Ltd.
7.91M
0.83%
+794.94K
+11.18%
Sep 30, 2025
Fiduciary Management, Inc.
7.18M
0.75%
-284.22K
-3.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
4.44M
0.47%
-56.61K
-1.26%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.60M
0.27%
+171.68K
+7.08%
Sep 30, 2025
Causeway Capital Management LLC
1.96M
0.21%
+107.12K
+5.79%
Sep 30, 2025
Parametric Portfolio Associates LLC
1.83M
0.19%
+109.23K
+6.35%
Sep 30, 2025
Northern Trust Global Investments
1.64M
0.17%
+121.24K
+7.99%
Sep 30, 2025
Brandes Investment Partners, L.P.
1.62M
0.17%
+87.72K
+5.73%
Sep 30, 2025
Aperio Group, LLC
1.29M
0.14%
+13.78K
+1.08%
Sep 30, 2025
Envestnet Asset Management, Inc.
1.30M
0.14%
-51.03K
-3.78%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Langar Global HealthTech ETF
5.12%
Brandes International ETF
1.99%
Brandes US Small-Mid Cap Value ETF
1.17%
ActivePassive International Equity ETF
0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
0.14%
Avantis Responsible International Equity ETF
0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
0.1%
DFA Dimensional International Core Equity 2 ETF
0.09%
Avantis International Equity ETF
0.08%
Dimensional International Core Equity Market ETF
0.07%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Langar Global HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™5.12%
Brandes International ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.99%
Brandes US Small-Mid Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.17%
ActivePassive International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.14%
Avantis Responsible International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.1%
DFA Dimensional International Core Equity 2 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.09%
Avantis International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.08%
Dimensional International Core Equity Market ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.07%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™